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Tubulo-interstitial lesions mediate renal damage in adriamycin
glomerulopathy. The present study was designed to investigate the
relationship between proteinuria, focal sclerosis, and tubulo-interstitial
changes in the evolution of renal damage in experimental nephrosis. We
utilized an accelerated unilateral model of adriamycin (ADR) nephrosis
characterized by morphological changes more severe than in the
classical model. The first events in ADR-induced glomerulopathy were
epithelial cell damage and proteinuria. Subsequently, tubular casts were
formed at the distal level. The cast formation preceded the development
of interstitial damage, which was determined by tubular obstruction and
breaking of tubular basement membrane (TBM), which in turn pro-
moted an interstitial inflammatory reaction. Despite the severity of
tubulo-interstitial damage observed after a long period of heavy pro-
teinuria, the incidence of focal segmental glomerulosclerosis (FSG) was
very low. The results of the present study indicate that chronic
proteinuria is not necessarily accompanied by the development of focal
sclerosis. Tubulo-interstitial lesions appear to be the most important
determinant for the progression of renal damage in this model.
A single injection of 5 mg/kg of adriamycin (ADR) promotes
in rat a state of heavy and persistent proteinuria [1]. Proteinuria
appears a few days after the injection of the drug and persists
for several months. In a previous study [2], we have shown that
a six—month period of high urinary protein excretion in 60% of
animals induced the development of focal and segmental gb-
merulosclerosis (FSG). The focal and segmental changes were
associated with pronounced tububo-interstitial changes consist-
ing of the presence of large tubular casts, tubular dilatation,
interstitial fibrosis and inflammation. However, in the remain-
ing animals FSG was not detected and tububo-interstitial
changes were rather mild. After nine months of sustained
urinary protein excretion, all rats developed FSG of moderate
severity, once again associated with severe tubulo-interstitial
changes and with a moderate degree of renal insufficiency [21.
The findings of our previous study suggested a possible linkage
between glomerulosclerosis and tubulo-interstitial changes,
however the temporal sequence of events and the dynamic
process leading to tubulo-interstitial changes were not fully
clarified.
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The present investigation was designed to examine the rela-
tionship between proteinuria, focal sclerosis, and tubulo-in-
terstitial changes in ADR nephrosis; and, furthermore, to
establish which of the above mentioned phenomena plays the
most relevant role in the evolution of renal damage in this
model. To address this issue we utilized a new unilateral model
of ADR nephrosis in which pathological changes, restricted to
one kidney alone, were significantly more severe if compared
with those observed in the classical model. Proteinuria was
very pronounced, the ultrastructural changes of podocytes
were dramatic, and after two weeks many proteinaceous casts
were detected in the lumens of distal tubules. We defined this
model as "accelerated ADR nephrosis". It offered the oppor-
tunity to evaluate in a shorter period of time the pathological
changes in many aspects similar to those seen after several
months of proteinuria in the classical model. The results of
these studies demonstrate that in this model: a) proteinuria and
FSG are unrelated phenomena; and b) tubular cast formation is
the most important determinant in the progression of renal
damage.
Methods
Experimental design
The most employed model of ADR nephrosis contemplates a
dose of 7.5 mg/kg of the drug [31. However, recently it has been
reported that a single injection of lower doses (5 mg/kg and 3
mg/kg) promotes in rats a chronic proteinuria which persists for
several months [1, 2, 4]. Pathological changes, especially with
the dose of 3 mg/kg, appear to be less severe. The goal of our
experiment was to have a model able to potentiate the lesions
induced by a single intravenous injection of 7.5 mg/kg. This
could have been achieved by increasing the dose of ADR.
However, in our experience the use of 10 mg/kg of ADR leads
to a high mortality rate in the animals. Therefore, our efforts
were directed to find a way to increase the ADR nephrotoxicity
without exposing the animals to an increased risk of general
side effects.
The accelerated model of ADR nephrosis was carried out on
Sprague—Dawley CD-COBS male rats (Charles River Italia
S.p.A., Calco, Italy), weighing 280 to 300 g at the start of the
experiment. Animals were fed a standard diet and had free
access to water. Under ether anesthesia, the abdominal cavity
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*Group N
Serum creatinine
(mg/dl)
GFR
(ml/min/100 g body wt)
1 8 0.76 0.15 0.65 0.27
2 10 0.75 0.08 0.70 0.18
3 10 0.77 0.12 0.69 0.22
Controls 7 0.74 0.07 0.77 0.05
was opened through a midline incision and a clamp was placed
on the left renal artery. Immediately after, ADR (Adriblastina,
Farmitalia Carlo Erba, Milan, Italy) at the dose of 7.5 mg/kg
was injected intravenously. The clamp was removed eight
minutes later and the abdominal incision sutured, allowing rats
to recover from anesthesia. Animals tolerated the surgery quite
well. In selected animals a histological evaluation performed 24
or 48 hours after the drug injection did not reveal any significant
tubular damage. The overall mortality during the experimental
period did not exceed 25%. Animals were divided into three
groups.
Group 1. Sixteen rats underwent the accelerated model of
ADR glomerulopathy. Proteinuria was evaluated after 8, 14 and
16 days. On day 14, half the animals were killed and both their
kidneys examined by light microscopy (LM), immunofluores-
cence (IF), and electron microscopy (EM). In the other 50% of
rats, the unclamped kidney was removed on day 14 in order to
demonstrate the unilaterality of the disease, and on day 16 the
animals were killed. The clamped kidney was used for patho-
logical studies.
Group 2. Ten rats underwent the accelerated model of ADR
nephrosis. Proteinuria was evaluated after 8, 14 and 28 days.
Minutes Clamped kidneyb Unclamped kidney"
2 0.73 0.59 58.38 27.76
5 1.26 0.46 97.17 9.53
10 4.14 2.09 115.14 25.07
15 4.51 0.36 77.05 6.28
30 10.50 3.66 72.44 11.85
60 8.90 2.01 48.89 13.32
Animals were killed at day 28 and both kidneys were used for
pathological studies.
Group3. Thirty—two rats underwent the accelerated model of
ADR glomerulopathy. Proteinuria was evaluated after 8, 14, 28
and 60 days. A bilateral renal biopsy was performed at day 14.
On day 60, all animals were killed and both kidneys removed
for histological examination. An additional group (Group 4) was
used to study kidney distribution of ADR as described below.
Renal distribution of ADR
Twenty-four rats were treated in the same way of previous
groups up to the clamp removal, eight minutes after the end of
ADR injection. Four animals per point were killed 2, 5, 10, 15,
30, and 60 minutes after ADR injection. Left and right kidneys
were removed separately and immediately frozen at —20°C until
analysis. Tissue samples were assayed as previously described
[5, 61. Kidneys were homogenized in five volumes of water. To
0.5 ml of homogenate, 50 pJ of a solution (20 ml) containing
ADR as internal standard and 30 pi of 33% AgNO3 were added.
The samples were then extracted with 8 ml of isopropanol. The
organic phase was evaporated under vacuum. Dried samples
were redissolved with 100 d of mobile phase and injected into
a Perkin Elmer series 3B high—performance liquid chrom-
atograph with a fluorescence detector (Perkin Elmer 650/10,
Perkin Elmer, Norwalk, Connecticut, USA) at an excitation
wavelength of 475 nm and an emission wavelength of 580 nm.
Separation was achieved by an isocratic solvent system of
acetonitrile:water:0. 1 M phosphoric acid (34:40:26) at a flow
rate of 1.2 mI/mm on a 25 cm "Li Chrosorb" C-18 column (E.
Merck, Darmstadt, Federal Republic of Germany). The sensi-
tivity limit was 10 ng/g of tissue.
Pathological studies
Light microscopy. Fragments of kidneys were fixed in
Dubosq—Brazil fluid (80% alcohol, 150 ml; formol, 60 ml; acetic
acid, 15 ml; picric acid, 1 g and embedded in paraffin. Sections
3 ,tt thick were stained with Masson's trichrome, hematoxylin
and eosin, periodic acid staining (periodic acid—Schiff), and
Wilder's reticulin.
Immunopathology. Small pieces of kidney were snap—frozen
in liquid nitrogen. Frozen sections of cortex and of medulla
were cut at 3 x on a cryostat (Ames Company, Miles Labora-
tories, Cavenago, Italy). Sections were fixed in acetone for 10
minutes and subsequently washed in phosphate—buffered saline
(PBS). Then they were treated with fluorescein conjugated
antisera to rat immunoglobulins, complement and albumin
(N.L. Cappel Laboratories, Inc., West Chester, Pennsylvania,
Table 2. Renal distribution of ADR at different times after injection in
rats with left clamped kidney"
1500
1200
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Days
Fig. 1. Protein excretion in rats with the accelerated model of ADR
nephrosis at various intervals after a single iv. ADR injection. Results
are expressed as means SD.
Table 1. Serum creatinine and GFR measured in control rats and in
all groups of ADR-treated rats at the end of each experimental
period'
° Values are means SD.
b sg of ADR per g of tissue.
8 14 28 60
a Values are means SD.
* Group 1: ADR-treated rats killed on day 14; Group 2: ADR-treated
rats killed on day 28; Group 3: ADR-treated rats killed on day 60.
I'
•arr..
.
1 t. 
Fig. 2. Electron micrograph of clamped kidney /4 days after ADR injection. Note the absence of significant changes of the glomerular visceral
epithelial cell (x 3,000).
Fig. 3. Glomerulus of unclamped kidney 60 days after ADR injection showing a small area of segmental sclerotic changes with adhesion to
Bowman's capsule (Silver stain x 320).
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Table 3. Semiquantitative assessment of pathological changes in the
unclamped kidneys
Days Glomeruloscierosis
Tubular
casts
Tubular
dilatation
Interstitial
changes
14 0 ++ + 0
28
60 + +++ +++ +to++
Results
Time course of proteinuria
Fig. 4. Unclamped kidney 60 days after ADR injection. Note the
presence of a large amount of eosinophilic material in the tubular
lumens and some breaks of tubular basement membrane (arrows) with
extravasation of the tubular content in the interstitium (Silver stain x
208).
USA). Sections were also incubated with a fluorescein conju-
gated antiserum to Tamm—Horsfall protein (THP). We used
three different dilutions of THP 1:5, 1:10, and 1:20. Sections
were extensively washed in PBS and examined in a Leitz
microscope (Ernst Leitz, Wetzlar, Federal Republic of Ger-
many) under ultraviolet light using a Ploem epifluorescence
illuminator system.
Electron microscopy. Small fragments of kidney were fixed in
2.5% glutaraldehyde in 0.2 M phosphate buffer pH 7.4 for four
hours at room temperature. Samples were washed in phosphate
buffer and subsequently post-fixed in 1% osmium tetroxide at
4°C for one hour. After a brief wash in distilled water, they were
dehydrated through ascending grades of alcohol and embedded
in Epon resin. Sections were cut on an LKB V ultramicrotome
(LKB Instruments, Milan, Italy). Semi-thin sections were
stained with toluidine blue in borax and examined by LM.
Ultrathin sections were stained with uranyl acetate and lead
citrate then examined with a Zeiss EM 109 (Carl Zeiss,
Oberkochen, Federal Republic of Germany).
Other investigations
Serum and urinary creatinine were determined by the method
of Hare Li] using a Beckman analyzer (Astra 4 model, Beckman
Instruments Inc., Fullerton, California, USA) in all groups of
ADR treated animals and in seven normal rats used as controls.
Urine was collected using metabolic cages over a 24-hour
period and proteinuria was determined by the sulfosalicylic acid
method.
Results were analyzed by unpaired Student's t-test and
Duncan's range test.
All treated animals were heavily proteinuric (464 161
mg/day) eight days after the ADR injection. In Group I the
severe proteinuria, detected at day eight, fell to an almost
physiological range (21 5 mg/day) after the removal of the
unclamped kidney, thus demonstrating that the glomerular
damage was restricted to the unclamped kidney. Proteinuria
was found to be further increased at days 14 (544 178
mg/day), 28 (760 145 mg/day) in Groups 2 and 3, and 60 (982
330 mg/day) in the Group 3. Figure 1 shows the time course
of proteinuria throughout the experimental period in these
animals.
Renal function
In all groups of animals treated with ADR, glomerular filtra-
tion rate (GFR), measured as clearance of endogenous creati-
nine at the end of the experimental period, was not different
from the values found in control rats (Table 1).
Distribution of ADR in the kidneys
These studies were designed to assess whether the protective
effect of an eight minutes' clamping on the left kidney was due
to a different exposure of the two kidneys to ADR. For this
purpose, we followed ADR concentrations in unclamped and
clamped kidneys at different intervals after ADR injection. As
shown in Table 2, the initial kidney distribution and the subse-
quent disposal of ADR in clamped and unclamped kidneys were
greatly different for each of the experimental points considered.
Thus, the short period of clamping effectively protects the
clamped kidney from ADR toxicity. The fact that at 30 and 60
minutes we found low but measurable levels of ADR also in the
clamped kidney probably accounts for the modest histological
changes observed 60 days after ADR injection.
Morphological studies
Clamped kidney. By LM no significant changes were de-
tected at 14, 16, and 28 days after ADR injection. However, at
day 60 animals showed minimal glomerular changes consisting
of a moderate swelling of glomerular podocytes. Occasional
casts were found in the lumens of distal tubules. The EM
examination of clamped kidneys was in agreement with LM
findings. Whereas at days 14, 16, and 28 no evident changes in
the siructure of podocytes could be detected (Fig. 2), at day 60
focal fusions' of foot processes, focal increase in reabsorption
droplets, and blebbing were present. The cytoplasm of proximal
tubular cells contained some protein droplets and in the lumens
of distal tubules some fairly homogeneous casts were seen. IF
findings were essentially negative, except for the THP staining
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Fig. 5. Unclainped kidney 60 days after ADR injection. Glomerulus shows only minor sclerotic changes. Many casts are present in the tubular
lumens. In some areas tubular basement membrane is thickened or broken (arrows). Tubular changes are associated with an interstitial
inflammatory reaction (Silver stain X 80).
and for albumin of occasional tubular casts in those animals
which at day 60 were affected by some histological changes.
Unclamped kidney. By LM at day 14, glomerular visceral
epithelial cells showed a pronounced swelling of their cyto-
plasm with an increased number of reabsorption vacuoles and
lysosomes as well as segmental detachment of epithelial cells
from the basement membrane. The other glomerular structures
appeared normal. However, most distal tubules were filled with
a large number of eosinophilic casts. Concomitantly in the
cytoplasm of many proximal tubules many protein droplets
were seen, demonstrating the intense reabsorption activity of
proximal tubular cells consequent to a large—scale proteinuria.
At day 28 glomerular changes seen by LM were in several
aspects similar to those described after 14 days. In particular,
despite the severe proteinuria, areas of glomerulosclerosis were
not detectable in any of the glomeruli examined. By contrast
tubular casts were bigger, with a consequent marked tubular
dilatation. At that lime, interstitial inflammation and fibrosis
were unremarkable. Sixty days after ADR injection in 5% of
glomeruli limited areas of focal glomerulosclerosis were found.
Compared with the previous model of nine months chronic
protcinuria, in the accelerated model described in this study,
FSG was significantly less pronounced as far as the percentage
of affected glomeruli and the extent of glomerular sclerosis (Fig.
3). Tubular changes were impressive in most animals: the size
of casts appeared to be further increased and tubular dilatation
became very pronounced, leading to some discontinuities of the
tubular basement membrane (TBM) (Figs. 4 and 5). Moreover
interstitial inflammatory and fibrotic changes were seen in most
animals, although significantly less pronounced than in the nine
months model (Table 3). By IF at days 14 and 28 no significant
deposits of rat immunoglobulins or C3 were detected in
glomcruli; after 60 days scattered deposits of immunoglobulins
and C3 were seen only in some glomeruli. The most interesting
Fig. 6. Kidney section of unclamped kidney 60 days after ADR treat-
ment. Note the intense staining for THP in tubular casts and in some
interstitial areas (x 250).
immunopathological findings were in the tubules. All casts were
strongly positive for albumin and THP. Moreover, in the
animals with the most severe tubular interstitial changes, THP
staining was also detected in some interstitial areas, probably as
a consequence of rupture of the TBM and of extravasation of
the casts in the interstitium (Fig. 6). l'he ultrastructural studies
performed 14 days after ADR injection revealed the usual
changes at the level of glomerular visceral epithelial cells:
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Fig. 7. Electron ,nicrograph of unclamped kidney 14 days after ADR injection. Note the severe changes of glomerular podocytes with extensive
'fusion' of foot processes (x 3,000).
extensive fusion of foot processes, increase in reabsorption
droplets and blebbing (Fig. 7). Proximal tubular cells contained
protein reabsorption droplets, whereas in the lumens of distal
tubules fairly homogeneous casts were seen. Glomerular and
tubular changes worsened 28 days after ADR injection. At day
60, by the end of the experimental period, glomerular lesions
became more complex. In addition to the severe changes of
glomerular visceral epithelial cells, a moderate swelling of
endothelial cells and an irregular expansion of the mesangial
matrix were seen (Fig. 8).
Discussion
The present study describes an accelerated model of ADR
nephrosis characterized by pathological changes confined to the
unclamped kidney. The clamped kidney appeared normal at
least until 28 days after the i.v. injection of ADR. The mecha-
nism by which eight minutes' clamp effectively protects the
clamped kidney from ADR toxicity should be attributed to the
rapid disappearance of ADR from the circulation for its rapid
entry into cells and tissues [8, 91. On the basis of our pharma-
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Fig. 8A and B. Electron micrographs of unclainped kidney 60 days after ADR injection. Note the complete obliteration of foot processes and the
degenerative changes in the cytoplasm of glomerular podocytes (X 7,000).
cological studies, it is reasonable to postulate that few minutes
after the iv. injection, plasma ADR concentration is too low to
induce renal damage. Conversely, as result of an increased
blood flow to the unclamped kidney, the latter may he exposed
to a higher amount of ADR in this model than in the classical
one, and the toxic effect of the drug on the glomerular struc-
tures is potentiated. This conclusion is supported by our
observation that morphological damage to the affected kidney
and proteinuria were both more severe in this model than in the
classical one.
Recently a model consisting of repeated injections of ADR in
rats undergoing unilateral nephrectomy has also been reported
[101. Although the period of study of the pathological changes
was not extended over 20 days, glomerular and tubular damage
was closely similar to that seen in our model. The advantage of
the model described here is that the presence of a normal
kidney allows a better evaluation of the sequence of morpho-
logical changes in the affected kidney, avoiding the profound
hemodynamic modification induced by unilateral nephrectomy.
Despite the similarity between the classical model and the
accelerated one, in the latter, FSG appeared to develop in a
lower percentage of glomeruli [1, 2]. However, in both models
tubulo-interstitial damage was the prominent morphological
finding associated with ADR-induced chronic proteinuria.
Glomerular sclerosis and tubulo-interstitial changes have been
also observed in rabbits after several months following a
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Fig. 8B.
treatment with multiple injections of ADR. However, the extent
and the characters of FSG have not been described in detail
[11].
After a single i.v. injection of ADR, proteinuria remains at a
high level for several months [1, 2], with a gradual increase
between months six and nine. According to our previous
studies [1, 2] such a long period of heavy proteinuria does not
produce FSG in all animals. We show with the present inves-
tigation that in the unilateral model, characterized by more
severe changes, the incidence of FSG is even lower. These
observations are consistent with the hypothesis that heavy
proteinuria and FSG are unrelated phenomena. In this context,
Grond and associates [4] have recently shown that rats made
nephrotic with a lower dose of ADR than used by our group
developed FSG only in a very low percentage of glomeruli in
respect to animals treated with repeated injections of
puromycin aminonucleoside.
In consideration of the striking similarities between the two
models [3, 12, 13] it has been suggested that the normal function
of the mesangium is the main reason for the low incidence of
FSG in ADR nephrosis. This possibility is supported by exper-
imental data showing alteration of mesangial function in chronic
aminonucleoside, but not in ADR nephrosis [4]. As indicated by
the above mentioned authors, overloading of the mesangium
might trigger an excessive production of matrix substance and
promote the development of FSG. Therefore, increased capil-
lary permeability and development of FSG should be consid-
ered separate 'sequelae' of glomerular damage rather than
causally related phenomena. The present study does not con-
tribute to clarify whether 'mesangium overloading' is the main
pathogenetic factor in the development of FSG; however, it
adds to the available evidence [4], indicating a poor association
between chronic proteinuria and the development of focal
sclerosis.
As far as the pathogenesis of glomerular sclerosis, the close
relationship between FSG and tubulo-interstitial changes in the
nine months' model [1, 2] suggested to us a possible cause and
effect relationship between the two lesions. In the present study
we have documented that epithelial cell abnormalities and
proteinuria are the first events in ADR-induced glomeru-
lopathy. Subsequently, probably as a result of heavy protein-
uria, tubular casts are formed at the distal level. The cast
formation largely precedes the onset of FSG and the develop-
ment of interstitial damage. We propose the following sequence
of events: the massive entry of circulating proteins into urinary
space leads to the formation in the lumen of distal tubules of
casts, which progressively increase in size and cause obstruc-
tion followed by breaking of TBM. These changes might be
responsible for the interstitial inflammatory reaction, which
might favor the development of glomerulosclerosis [1, 2]. The
intense staining for THP of some interstitial areas we have
observed with immunofluorescence suggests that THP might
have a role in determining interstitial damage.
Taken all together, the data obtained in both the nine months
and the accelerated model of ADR nephrosis indicate that ADR
exerts a direct toxicity on glomerular structure responsible for
changes in glomerular permeability and proteinuria. This con-
cept is suggested by previous studies [1, 4] in which ADR has
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been employed for unilateral kidney perfusion [141. At vari-
ance, tubulo-interstitial damage does not appear to be due to a
direct toxicity of the drug, but rather a consequence of
long—lasting proteinuria inducing cast formation and interstitial
inflammatory reaction.
Whether the sequence of events proposed here as responsible
for the progression of ADR nephropathy also applies to some
proteinuric conditions in man is open to speculation. Of interest
is the observation that in humans affected by reflux nephrop-
athy, the late development of FSG is preceded by tubulo-
interstitial changes. The experiments presented here, however,
are not sufficient to rule out the possibility that FSG and
tubulo-interstitial damage are two unrelated phenomena both
consequent to proteinuria.
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